1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Screening for cancer with PET and PET/CT: Potential and limitations
    Journal Article

    Schoder, H.; Gonen, M.
    Journal of Nuclear Medicine (2007)

    Fulltext@MSK | Save
  • Routine drainage after thyroid surgery - A meta-analysis
    Journal Article

    Sanabria, A.; Carvalho, A. L.; Silver, C. E.; Rinaldo, A.; Shaha, A. R.; Kowalski, L. P.; Ferlito, A.
    Journal of Surgical Oncology (2007)

    Fulltext@MSK | Save
  • Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: Results of CALGB 89803
    Journal Article

    Saltz, L. B.; Niedzwiecki, D.; Hollis, D.; Goldberg, R. M.; Hantel, A.; Thomas, J. P.; Fields, A. L. A.; Mayer, R. J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: The BOND-2 study
    Journal Article

    Saltz, L. B.; Lenz, H. J.; Kindler, H. L.; Hochster, H. S.; Wadler, S.; Hoff, P. M.; Kemeny, N. E.; Hollywood, E. M.; Gonen, M.; Quinones, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Immunologic approaches to ovarian cancer treatment
    Journal Article

    Sabbatini, P.; Odunsi, K.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients: Randomized phase 2 study of ixabepilone or mitoxantrone and prednisone
    Journal Article

    Rosenberg, J. E.; Weinberg, V. K.; Kelly, W. K.; Michaelson, D.; Hussain, M. H.; Wilding, G.; Gross, M.; Hutcheon, D.; Small, E. J.
    Cancer (2007)

    Fulltext@MSK | Save
  • Bevacizumab 5 mg/kg can be infused safely over 10 minutes
    Journal Article

    Reidy, D. L.; Chung, K. Y.; Timoney, J. P.; Park, V. J.; Hollywood, E.; Sklarin, N. T.; Muller, R. J.; Saltz, L. B.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Skin squamous cell cancer: The time is right for greater involvement of the medical oncologist
    Journal Article

    Pfister, D. G.; Halpern, A. C.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors
    Journal Article

    Motzer, R. J.; Nichols, C. J.; Margolin, K. A.; Bacik, J.; Richardson, P. G.; Vogelzang, N. J.; Bajorin, D. F.; Lara, P. N. Jr; Einhorn, L.; Mazumdar, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Tomczak, P.; Michaelson, D.; Bukowski, R. M.; Rixe, O.; Oudard, S.; Negrier, S.; Szczylik, C.; Kim, S. T.; more...
    New England Journal of Medicine (2007)

    Fulltext@MSK | Save